NUK - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov NUK. Za polni dostop se PRIJAVITE.

1 2 3 4 5
zadetkov: 203
1.
  • Modern therapy of acute lymphoblastic leukemia
    Bassan, Renato; Hoelzer, Dieter Journal of clinical oncology, 2011-Feb-10, Letnik: 29, Številka: 5
    Journal Article
    Recenzirano

    Although acute lymphoblastic leukemia is curable in one third of adult patients, results vary greatly on account of different clinical, immunologic, and cytogenetic/genetic characteristics. These ...
Celotno besedilo
2.
  • Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
    Kantarjian, Hagop; Stein, Anthony; Gökbuget, Nicola ... The New England journal of medicine, 03/2017, Letnik: 376, Številka: 9
    Journal Article
    Recenzirano
    Odprti dostop

    Blinatumomab, a bispecific monoclonal antibody construct that enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic leukemia (ALL) blasts, was approved for use in ...
Celotno besedilo

PDF
3.
  • Treatment and monitoring of... Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges
    Soverini, Simona; Bassan, Renato; Lion, Thomas Journal of hematology and oncology, 04/2019, Letnik: 12, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    The Philadelphia (Ph) chromosome, resulting from the t(9;22)(q34;q11) translocation, can be found in chronic myeloid leukemia (CML) as well as in a subset of acute lymphoblastic leukemias (ALL). The ...
Celotno besedilo

PDF
4.
  • Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
    Foà, Robin; Bassan, Renato; Vitale, Antonella ... The New England journal of medicine, 10/2020, Letnik: 383, Številka: 17
    Journal Article
    Recenzirano
    Odprti dostop

    Outcomes in patients with Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) have improved with the use of tyrosine kinase inhibitors. Molecular remission is a primary goal of ...
Celotno besedilo

PDF
5.
  • A systematic literature rev... A systematic literature review and meta-analysis of minimal residual disease as a prognostic indicator in adult B-cell acute lymphoblastic leukemia
    Bassan, Renato; Brüggemann, Monika; Radcliffe, Hoi-Shen ... Haematologica (Roma), 10/2019, Letnik: 104, Številka: 10
    Journal Article
    Recenzirano
    Odprti dostop

    Minimal (or 'measurable') residual disease in acute lymphoblastic leukemia appears to be a prognostic indicator, with potential value in informing individualized treatment decisions. Complete ...
Celotno besedilo

PDF
6.
  • Diagnosis and subclassifica... Diagnosis and subclassification of acute lymphoblastic leukemia
    Chiaretti, Sabina; Zini, Gina; Bassan, Renato Mediterranean journal of hematology and infectious diseases, 01/2014, Letnik: 6, Številka: 1
    Journal Article
    Odprti dostop

    Acute lymphoblastic leukemia (ALL) is a disseminated malignancy of B- or T-lymphoblasts which imposes a rapid and accurate diagnostic process to support an optimal risk-oriented therapy and thus ...
Celotno besedilo

PDF
7.
  • International reference ana... International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia
    Gökbuget, Nicola; Dombret, Hervè; Ribera, Jose-Maria ... Haematologica (Roma), 12/2016, Letnik: 101, Številka: 12
    Journal Article
    Recenzirano
    Odprti dostop

    Adults with relapsed/refractory acute lymphoblastic leukemia have an unfavourable prognosis, which is influenced by disease and patient characteristics. To further evaluate these characteristics, a ...
Celotno besedilo

PDF
8.
  • Practical guidance for the ... Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population
    Carobolante, Francesca; Chiaretti, Sabina; Skert, Cristina ... Therapeutic Advances in Hematology, 01/2020, Letnik: 11
    Book Review, Journal Article
    Recenzirano
    Odprti dostop

    The outstanding therapeutic progress achieved with modern pediatric regimens in childhood acute lymphoblastic leukemia (ALL) led efforts to explore whether a similar treatment approach could be ...
Celotno besedilo

PDF
9.
  • Lymphoblastic Lymphoma: a C... Lymphoblastic Lymphoma: a Concise Review
    Intermesoli, Tamara; Weber, Alessandra; Leoncin, Matteo ... Current oncology reports, 2022/1, Letnik: 24, Številka: 1
    Journal Article
    Recenzirano

    Purpose of Review Lymphoblastic lymphoma (LBL) is a rare, highly aggressive non-Hodgkin lymphoma variant virtually indistinguishable from acute lymphoblastic leukemia (ALL). We review the ...
Celotno besedilo
10.
  • Improved risk classificatio... Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
    Bassan, Renato; Spinelli, Orietta; Oldani, Elena ... Blood, 04/2009, Letnik: 113, Številka: 18
    Journal Article
    Recenzirano
    Odprti dostop

    Clinical risk classification is inaccurate in predicting relapse in adult patients with acute lymphoblastic leukemia, sometimes resulting in patients receiving inappropriate chemotherapy or stem cell ...
Celotno besedilo
1 2 3 4 5
zadetkov: 203

Nalaganje filtrov